000			01610 a2200481 4500
005			20250512024250.0
264		0	_c19901115
008			199011s 0 0 eng d
022			_a0927-3042
024	7		_a10.1007/978-1-4613-1083-9_29 _2doi
040			_aNLM _beng _cNLM
100	1		_aVallera, D A
245	0	0	_aImmunotoxins for ex vivo bone marrow purging in human bone marrow transplantation. _h[electronic resource]
260			_bCancer treatment and research _c1988
300			_a515-35 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBone Marrow Transplantation
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCombined Modality Therapy
650	0	4	_aGraft Rejection
650	0	4	_aGraft vs Host Disease _xprevention & control
650	0	4	_aHumans
650	0	4	_aImmunotoxins _ximmunology
650	0	4	_aInfant
650	0	4	_aLeukemia _xdrug therapy
650	0	4	_aLeukemia, Experimental _ximmunology
650	0	4	_aLymphocyte Depletion
650	0	4	_aMice
650	0	4	_aMiddle Aged
650	0	4	_aNeoplastic Stem Cells _xdrug effects
650	0	4	_aPreoperative Care
650	0	4	_aRadioisotopes _xadministration & dosage
650	0	4	_aRats
650	0	4	_aToxins, Biological _xpharmacology
650	0	4	_aTransplantation, Homologous
773	0		_tCancer treatment and research _gvol. 37 _gp. 515-35
856	4	0	_uhttps://doi.org/10.1007/978-1-4613-1083-9_29 _zAvailable from publisher's website
999			_c2914487 _d2914487